Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04147624 · ClinicalTrials.gov registry record · Phase 2

Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial

A Phase 2 study, sponsored by University of Miami.

Completed
Registry status
Phase 2
Development phase
67
Enrollment target

NCT04147624 is a Phase 2 study that has completed, run by University of Miami. The registered enrollment target is 67 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04147624, a Phase 2 study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
Phase 2
Development phase
67 participants
Enrollment target

Study Summary

The purpose of this research is to assess the feasibility (e.g., recruitment rate, adherence rate and retention rate) of a clinical trial using virtual assessments to investigate the effect of a 6-month administration of a specific multi-nutrient oral supplement on cognitive aging. The study will also test whether a 6-month daily intake of a specific multinutrient can delay or reverse the effects of normal cognitive aging on other cognition domains as well as quality of life as measured by virtual assessments.

Interventions

  • OTHER Placebo
  • DRUG Souvenaid

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2021-06-04
Est. Completion 2022-12-02
Phase Phase 2

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT04147624

The ClinicalTrials.gov registry entry for NCT04147624 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 67 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT04147624 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04147624 about?

NCT04147624 is a clinical study titled "Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial". The purpose of this research is to assess the feasibility (e.g., recruitment rate, adherence rate and retention rate) of a clinical trial using virtual assessments to investigate the effect of a 6-month administration of a specific multi-nutrient oral supplement on cognitive aging. The study will a...

What is the current status of trial NCT04147624?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 67 participants. The study started on 2021-06-04. Estimated completion is 2022-12-02.

What interventions are being tested in trial NCT04147624?

The interventions under investigation include: Placebo (OTHER), Souvenaid (DRUG).

Who is sponsoring clinical trial NCT04147624?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.